Literature DB >> 17346664

PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.

Huijie Zhang1, Rongbiao Pi, Ruifang Li, Ping Wang, Futian Tang, Sigui Zhou, Jie Gao, Jianmin Jiang, Shaorui Chen, Peiqing Liu.   

Abstract

Peroxisome proliferator-activated receptors (PPARalpha, beta/delta and gamma) are nuclear receptors and PPARgamma activation was previously reported to inhibit collagen expression in the heart, but whether PPARbeta/delta also regulates collagen expression in the heart remains unclear. In this study, we investigated the effect of PPARbeta/delta activation on angiotensin II (Ang II)-induced collagen type I expression in adult rat cardiac fibroblasts. The results showed that PPARbeta/delta was expressed at the moderate level in cardiac fibroblasts. GW501516, a selective PPARbeta/delta agonist, depressed Ang II-stimulated collagen type I expression and collagen synthesis in cardiac fibroblasts in a concentration-dependent manner. Furthermore, these inhibitory effects of GW501516 were completely reversed by the knockdown of PPARbeta/delta via RNA interference. In summary, we find that PPARbeta/delta is present in cardiac fibroblasts and PPARbeta/delta activation inhibits Ang II-induced collagen type I expression at least in part via decreasing collagen synthesis. PPARbeta/delta may be a promising therapeutic target for myocardial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346664     DOI: 10.1016/j.abb.2007.01.028

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

Review 1.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

2.  Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.

Authors:  Dmitry L Sonin; Tetsuro Wakatsuki; Kasi V Routhu; Leanne M Harmann; Matthew Petersen; Jennifer Meyer; Jennifer L Strande
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-04-17       Impact factor: 2.457

3.  Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro.

Authors:  Le Yang; Xiao-Jing Zou; Xiang Gao; Hao Chen; Jin-Long Luo; Zhao-Hua Wang; Qian-Sheng Liang; Guang-Tian Yang
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

4.  The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy.

Authors:  Baktybek Kojonazarov; Himal Luitel; Akylbek Sydykov; Bhola K Dahal; Mark J Paul-Clark; Sara Bonvini; Anna Reed; Ralph T Schermuly; Jane A Mitchell
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 5.  Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2009-06-06

Review 6.  PPARs and the cardiovascular system.

Authors:  Milton Hamblin; Lin Chang; Yanbo Fan; Jifeng Zhang; Y Eugene Chen
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

7.  The Antifibrosis Effects of Peroxisome Proliferator-Activated Receptor δ on Rat Corneal Wound Healing after Excimer Laser Keratectomy.

Authors:  Yun Gu; Xuan Li; Tiangeng He; Zhixin Jiang; Peng Hao; Xin Tang
Journal:  PPAR Res       Date:  2014-11-13       Impact factor: 4.964

8.  PPARδ agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodeling.

Authors:  Guangjie Liu; Xuan Li; Yan Li; Xin Tang; Jie Xu; Ran Li; Peng Hao; Yongchang Sun
Journal:  Biomed Res Int       Date:  2013-03-27       Impact factor: 3.411

9.  PPARδ activity in cardiovascular diseases: A potential pharmacological target.

Authors:  Angela Tesse; Ramaroson Andriantsitohaina; Thierry Ragot
Journal:  PPAR Res       Date:  2009-03-23       Impact factor: 4.964

10.  Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms.

Authors:  Belén Picatoste; Elisa Ramírez; Alicia Caro-Vadillo; Cristian Iborra; Sara Ares-Carrasco; Jesús Egido; José Tuñón; Oscar Lorenzo
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.